Patient perspectives can shape trial design.

Design your trials around patients as well as products. With tools to measure, analyze and improve patient experience in trials, support regulatory approval and differentiate your drug for payers.

Contact Us
The FDA and EMA have begun to strongly request that Patient Reported Outcomes data be considered in the assessment of clinical trial endpoints
Jean Paty, Vice President, Patient Centered Endpoints, IQVIA

A difference you can measure

As part of the 2016 21st Century Cures Act, the FDA allowed companies to provide "data summaries," real world evidence, and anecdotal data to support approval of new indications, including a required statement on patient experience data. That reflects a growing number of patients who want their voices to be heard, from trials to treatment plans.

IQVIA can help you meet those expectations and make the patient experience a meaningful measure of therapeutic value.


IQVIA’s Clinical Outcome Assessment (COA) Process

Our solutions are designed to dovetail with existing internal capabilities, so from strategy development to regulator and payer communications, you have what you need to amplify the patient perspective.

patient centered endpoints
female checking her smartwatch
female checking her smartwatch

Seamlessly integrate digital data

Widespread use of mobile devises is bringing patients closer to trials than ever before, from enabling remote recruitment to giving patients an "always on" way to report information about symptoms and quality of life.

IQVIA's e-Clinical Outcome Assessment (eCOA) seamlessly integrates self-reported data from patients into the overall endpoints reporting process. So internal and external stakeholders can seamlessly extract insights from traditional and digital data.

Start with experiences, not assumptions

Beyond meeting regulatory and payer asks, taking patient feedback into account can change the way your trials work, and the quality of your outcomes. Listening to patients can give you a different point of view on what constitutes better treatment. So you can design trials that respond to what patients value, and get to better treatments faster.

That in turn can support significant differentiation and attendant advantages, both in gaining market access, achieving regulatory acceptance and finding the highest and best applications for your therapy.

Learn More
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.